CUBIST PHARMACEUTICALS INC
10-Q, EX-27, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: CUBIST PHARMACEUTICALS INC, 10-Q, 2000-11-14
Next: G&L REALTY CORP, 10-Q, 2000-11-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JUL-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                      80,105,744
<SECURITIES>                                         0
<RECEIVABLES>                                  500,000
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            82,517,373
<PP&E>                                      44,910,097
<DEPRECIATION>                             (6,067,727)
<TOTAL-ASSETS>                             195,724,679
<CURRENT-LIABILITIES>                        7,627,869
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        27,201
<OTHER-SE>                                 146,837,166
<TOTAL-LIABILITY-AND-EQUITY>               195,724,679
<SALES>                                              0
<TOTAL-REVENUES>                             1,062,500
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                            11,399,701
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           2,328,050
<INCOME-PRETAX>                            (8,009,151)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (8,009,151)
<EPS-BASIC>                                      (.30)
<EPS-DILUTED>                                    (.30)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission